Table 6 Frequency and prevalence (%) of representatives of HPV grouped by age, nationality and year
HPV16 | HPV52 | HPV53 | HPV58 | |
|---|---|---|---|---|
Age | ||||
≤ 25 | 78 (4.36%) | 59 (3.30%) | 32 (1.79) | 41 (2.29%) |
26–30 | 182 (3.70%) | 130 (2.64%) | 61 (1.24%) | 74 (1.50%) |
31–35 | 227 (3.86%) | 136 (2.31%) | 65 (1.11%) | 114 (1.94%) |
36–40 | 313 (4.94%) | 185 (2.92%) | 98 (1.55%) | 135 (2.13%) |
41–45 | 283 (4.02%) | 184 (2.61%) | 92 (1.31%) | 120 (1.70%) |
46–50 | 178 (3.29%) | 124 (2.29%) | 81 (1.50%) | 93 (1.72%) |
51–55 | 88 (2.79%) | 61 (1.93%) | 56 (1.77%) | 45 (1.42%) |
≥ 56 | 113 (3.56%) | 74 (2.33%) | 35 (1.10%) | 58 (1.83%) |
Nation | ||||
Other | 17 (3.21%) | 19 (3.59%) | 2 (0.38%) | 15 (2.84%) |
Han | 1107 (3.79%) | 808 (2.77%) | 413 (1.42%) | 565 (1.94%) |
Hui | 58 (4.26%) | 42 (3.09%) | 19 (1.40%) | 32 (2.35%) |
Kazak | 63 (5.77%) | 8 (0.73%) | 18 (1.65%) | 17 (1.56%) |
Mongol | 22(4.55%) | 14(2.90%) | 8(1.66%) | 6 (1.24%) |
Uygher | 195(3.84%) | 62(1.22%) | 60(1.18%) | 45 (0.89%) |
Year | ||||
2009 | 140 (7.09%) | 55 (2.79%) | 35 (1.77%) | 59 (2.99%) |
2010 | 191 (8.23%) | 76 (3.27%) | 80 (3.45%) | 84 (3.62%) |
2011 | 157 (8.04%) | 47 (2.41%) | 32 (1.64%) | 63 (3.22%) |
2012 | 195 (8.29%) | 98 (4.17%) | 61 (2.59%) | 78 (3.32%) |
2013 | 167 (9.75%) | 106 (6.19%) | 71 (4.15%) | 88 (5.14%) |
2014 | 119 (8.02%) | 68 (4.59%) | 35 (2.36%) | 59 (3.98%) |
2015 | 108 (3.48%) | 106 (3.41%) | 42 (1.35%) | 51 (1.64%) |
2016 | 145 (2.18%) | 221 (3.31%) | 87 (1.31%) | 64 (0.96%) |
2017 | 103 (0.96%) | 94 (0.88%) | 36 (0.34%) | 65 (0.61%) |
2018 | 120 (2.24%) | 80 (1.49%) | 40 (0.74%) | 62 (1.16%) |